Mayne Pharma nears deal for Teva assets: source

(Reuters) – Australian pharmaceutical company Mayne Pharma Group Ltd is nearing a deal to purchase assets from Teva Pharmaceuticals worth around $600 million, a person familiar with the matter said on Monday.

Leave a Reply

Read the original at Reuters: Business News.